4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 1,125.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 1,820.00
  • 52 Week Low: 1,100.00
  • Currency: UK Pounds
  • Shares Issued: 15.50m
  • Volume: 2,569
  • Market Cap: £174.33m

Latest Deals

Traded Action Notifier PriceAmountValue
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,117,688 £12,573,990
Amy Walker 44,016 £495,180
Maria Del Pilar de la Huerta 6,667 £75,004
Hansjörg Plaggemars 6,667 £75,004
Timothy Paul McCarthy 2,388 £26,865

Major Shareholders

Notifier** Holding Value*
Wilhelm K. T. Zours 5,071,073 £57,049,571
DELPHI Unternehmensberatung AG 5,071,073 £57,049,571
M&G Plc 4,627,741 £52,062,086
Elevage Medical Technologies Holdings 4,627,741 £52,062,086
Deutsche Balaton AG 4,432,637 £49,867,166
4bb AG 3,665,242 £41,233,972
2invest AG 2,229,083 £25,077,184
Sparta AG 1,351,718 £15,206,828
Latonba AG 778,891 £8,762,524
Franciscus De Busschere 537,255 £6,044,119

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,125.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 1,820.00
52 Week Low 1,100.00
Volume 2,569
Shares Issued 15.50m
Market Cap £174.33m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.57% below the market average23.57% below the market average23.57% below the market average23.57% below the market average23.57% below the market average
31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average
Price Trend
7.95% below the market average7.95% below the market average7.95% below the market average7.95% below the market average7.95% below the market average
31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average
Income Not Available
Growth
39.23% above the market average39.23% above the market average39.23% above the market average39.23% above the market average39.23% above the market average
41.94% above the sector average41.94% above the sector average41.94% above the sector average41.94% above the sector average41.94% above the sector average

4basebio Dividends

No dividends found

Trades for 16-May-2025

Time Volume / Share Price
16:25 135 @ 1,147.00p
16:21 100 @ 1,147.00p
16:14 155 @ 1,147.00p
08:22 1,335 @ 1,122.50p
08:33 820 @ 1,132.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page